IGF2BP3 promotes the progression of gastric cancer by activating cGMP-PKG signaling pathway via targeting FBXO32
Y. Si, B. Tian, R. Zhang, M. Xuan, K. Liu, J. Jiao, S. Han, H. Li, Y. Hu, H. Zhao, W. He, J. Wang, T. Liu, W. Yu
This study identifies IGF2BP3 as a promoter of gastric cancer progression by upregulating FBXO32 via m6A binding and activating the cGMP-PKG signaling pathway.
bioRxiv · Jun 28, 2024 · PreprintCancer Biology